Temporary mechanical circulatory support for COVID-19 patients: A systematic review of literature.

Silvia MarianiMaria Elena De PieroJustine M Ravaux Alexander G SaelmansMichal J KawczynskiBas C T van BusselMichele Di MauroAnne WillersJustyna SwolMariusz KowalewskiTong LiThijs S R DelnoijIwan C C van der Horst Jos G Maessen Roberto Lorusso

Published in: Artificial organs (2022)

MCS use for cardiocirculatory compromise has been reported in 7.3% of COVID-19 patients requiring ECLS, which is a lower percentage compared to the incidence of any severe cardiocirculatory complication. Based on the poor survival rates, further investigations are warranted to establish the most appropriated indications and timing for MCS in COVID-19.

Keyphrases

sars cov
respiratory syndrome coronavirus
coronavirus disease
risk factors
early onset
extracorporeal membrane oxygenation
free survival